Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Merck, Australian & New Zealand Urogenital and Prostate Cancer Trials Group Limited (ANZUP)
Scientific Title
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma: a Phase II Trial